Curative Effect of Combined Hemihepatectomy and Perihilar Hepatectomy in Treatment of Hilar Cholangiocarcinoma

Liu-zheng LI; Shun LU; Shi-rong ZHANG; Lei-sheng XU; Hai-rong ZHAO; Jia-wei FENG; Xue-chan GAO; Tong WU

doi:10.12259/j.issn.2095-610X.S20211014

Volume 42 Issue 10

Oct. 2021

Turn off MathJax

Article Contents

Article Navigation > Journal of Kunming Medical University > 2021 > 42(10): 121-126

Liu-zheng LI, Shun LU, Shi-rong ZHANG, Lei-sheng XU, Hai-rong ZHAO, Jia-wei FENG, Xue-chan GAO, Tong WU. Curative Effect of Combined Hemihepatectomy and Perihilar Hepatectomy in Treatment of Hilar Cholangiocarcinoma[J]. Journal of Kunming Medical University, 2021, 42(10): 121-126. doi: 10.12259/j.issn.2095-610X.S20211014

Citation:

Liu-zheng LI, Shun LU, Shi-rong ZHANG, Lei-sheng XU, Hai-rong ZHAO, Jia-wei FENG, Xue-chan GAO, Tong WU. Curative Effect of Combined Hemihepatectomy and Perihilar Hepatectomy in Treatment of Hilar Cholangiocarcinoma[J]. Journal of Kunming Medical University, 2021, 42(10): 121-126. doi: 10.12259/j.issn.2095-610X.S20211014

Citation:

Liu-zheng LI, Shun LU, Shi-rong ZHANG, Lei-sheng XU, Hai-rong ZHAO, Jia-wei FENG, Xue-chan GAO, Tong WU. Curative Effect of Combined Hemihepatectomy and Perihilar Hepatectomy in Treatment of Hilar Cholangiocarcinoma[J]. Journal of Kunming Medical University, 2021, 42(10): 121-126. doi: 10.12259/j.issn.2095-610X.S20211014

PDF( 731 KB)

Curative Effect of Combined Hemihepatectomy and Perihilar Hepatectomy in Treatment of Hilar Cholangiocarcinoma

doi: 10.12259/j.issn.2095-610X.S20211014

Dept. of Hepatobiliary Surgery，Lincang People’s Hospital，Lincang Yunnan 677000，China

Received Date: 2021-07-24
Available Online: 2021-10-29
Publish Date: 2021-10-30

Abstract

Abstract

Objective To summarize the curative effect of different surgical resection methods for hilar cholangiocarcinoma （HCCA）. Methods The clinical data of 52 patients with HCCA who underwent surgery in Lincang people's Hospital from January 2015 to December 2020 were retrospectively analyzed. Among them, 36 cases were treated with hemihepatectomy/extended hemihepatectomy + total caudate lobectomy （combined hemihepatectomy group）, 16 cases of hilar/perihilar region + total caudate lobectomy （perihilar resection group）, The preoperative data, intraoperative blood loss, operation time, positive rate of tumor margin, postoperative hospital stay, CA19-9 value at 3 months after operation, and 1, 3-year survival rate of the two groups were compared and analyzed. Results The indexes of the combined hemihepatectomy group and perihepatectomy group were as following: the intraoperative blood loss [（705.5±54.3） mL vs （809.9±61.4） mL], the operation time [（240.4 ± 22.5） min vs （358.1 ± 31.1） min], the positive rate of tumor resection margin （8.3% vs 18.8%）, the negative rate of CA19-9 3 months after operation （88.2% vs 73.3%）, and the 1-year survival rate （58.8% vs 40.0%）. The difference was statistically significant between the two groups （P < 0.05）. Conclusion Combined hemihepatectomy and perihilar hepatectomy are effective surgical methods for HCCA, But the former has higher R0 resection rate and short-term survival rate.
- Keywords hilar tumor,
- Hepatectomy/method,
- Prognosis

FullText(HTML)

References(21)

References

[1]	Mansour J C,Aloia T A,Crane C H,et al. Hilar cholangiocarcinoma:expert consensus statement[J]. HPB(Oxford),2015,17(8):691-699.
[2]	Rizvi S,Khan S A,Hallemeier C L,et al. Cholangiocarcinoma- evolvingconcepts and therapeutic strategies[J]. Nat Rev Clin Oncol,2018,15(2):95-111. doi: 10.1038/nrclinonc.2017.157
[3]	中国抗癌协会. 肝门部胆管癌规范化诊治专家共识(2015)[J]. 中华肝胆外科杂志,2015,21(8):505-511. doi: 10.3760/cma.j.issn.1007-8118.2015.08.001
[4]	隋鑫磊,汤恢焕,肖广发,等. 肝门部胆管癌姑息治疗的效果及预后分析:附218例报告[J]. 中国普通外科杂志,2017,26(8):953-959. doi: 10.3978/j.issn.1005-6947.2017.08.001
[5]	Groot Koerkamp B,Wiggers J K,Allen P J,et al. Recurrence rate and pattern of perihilar cholangiocarcinoma after curative intent resection[J]. J Am Coll Surg,2015,221(6):1041-1049. doi: 10.1016/j.jamcollsurg.2015.09.005
[6]	Hu H J,Mao H,Shrestha A,et al. Prognostic factors and longterm outcomes of hilar cholangiocarcinoma:A single-institution experience in China[J]. World J Gastroenterol,2016,22(8):2601-2610. doi: 10.3748/wjg.v22.i8.2601
[7]	刘超. 日本名古屋大学肝门部胆管癌外科治疗策略[J]. 临床外科杂志,2020,28(8):704-706. doi: 10.3969/j.issn.1005-6483.2020.08.002
[8]	Feo C F,Ginesu G C,Barmina M,et al. Curative resection for hilar cholangiocarcinoma:single-center experience with long-term follow-up[J]. Am Surg,2018,84(1):9-10. doi: 10.1177/000313481808400106
[9]	Zhang X F,Squires M H,Bagante F,et al. The impact of intraoperative re-resection of a positive bile duct margin on clinical outcomes for hilar cholangiocarcinoma[J]. Ann Surg Oncol,2018,25(5):1140-1149. doi: 10.1245/s10434-018-6382-0
[10]	Tsuchikawa T,Hirano S,Okamura K,et al. Advances in thesurgical treatment of hilar cholangiocarcinoma[J]. Expert Rev Gastroenterol Hepatol,2015,9(3):369-374. doi: 10.1586/17474124.2015.960393
[11]	鲁正,王冬冬. Bismuth-CorletteⅢ、Ⅳ型肝门部胆管癌的手术治疗方式[J]. 中华外科杂志,2016,54(7):488-491. doi: 10.3760/cma.j.issn.0529-5815.2016.07.003
[12]	项灿宏,童翾. 肝门部胆管癌外科治疗的进展与争议[J]. 中国普通外科杂志,2018,27(2):137-142. doi: 10.3978/j.issn.1005-6947.2018.02.001
[13]	李炜,王敬晗,姜小清. 肝门部胆管癌外科治疗争议与进展[J]. 中国实用外科杂志,2020,40(4):472-476.
[14]	胡杨科,王珂,吴胜东,等. 肝门胆管癌外治疗进展[J]. 肝胆胰外科杂志,2019,(31):632-636.
[15]	晏益核,黄玉斌,蔡小勇. 肝门部胆管癌的外科治疗现状[J]. 中国普通外科杂志,2017,26(2):246-251.
[16]	CSCO 胆道肿瘤专家委员会. CSCO 胆道系统肿瘤诊断治疗专家共识(2019年版)[J]. 临床肿瘤学杂志,2019,24(9):828-838. doi: 10.3969/j.issn.1009-0460.2019.09.014
[17]	汪宏,姚小晓,乔士兴. 肝门部胆管癌手术切除范围的争议及诊疗进展[J]. 临床肝胆病杂志,2020,36(3):704-707. doi: 10.3969/j.issn.1001-5256.2020.03.053
[18]	李留峥,王峻峰,徐雷升,等. 肝门部胆管癌手术治疗:附44例报告[J]. 中国普通外科杂志,2021,30(2):140-150. doi: 10.7659/j.issn.1005-6947.2021.02.003
[19]	曾宁,杨剑,项楠,等. 三维可视化联合3D打印在BismuthCorlette III、IV型肝门部胆管癌个体化精准外科治疗中的应用[J]. 南方医科大学学报,2020,40(8):1172-1177.
[20]	叶征辉,黄帆. BismuthⅣ型肝门部胆管癌的手术治疗[J]. 肝胆外科杂志,2017,25(4):243.
[21]	崔云甫,徐艺. 肝门部胆管癌的外科治疗体会[J]. 中国普外基础与临床杂志,2016,23(11):1311-1314. doi: 10.7507/1007-9424.20160337

Relative Articles(20)

Relative Articles

[1]	Xinyi MEN, Jing ZHAO, Yongchun SHEN, Hui JI, Xiuxia WANG. The Relationship between Peripheral Blood Immunoglobulin，Erythrocyte Sedimentation Rate，Homocysteine and the Degree of Central Nervous System Vasculitis in Children and Their Influence on Prognosis. Journal of Kunming Medical University, 2024, 45(12): 1-7.
[2]	Bowen TAN, Yun LIANG, Huan CHEN, Yi LEI, Yuhan WANG, Yan TIAN. The Prognostic Value of Preoperative Peripheral Blood Inflammatory Markers Combined with Tumor Markers in Resectable Colon Cancer Patients. Journal of Kunming Medical University, 2024, 45(12): 1-5.
[3]	Ting GAO, Sheng HUANG, Rong GUO, Dedian CHEN. Clinicopathological Features and Prognosis of Mucinous Breast Carcinoma. Journal of Kunming Medical University, 2023, 44(3): 54-60. doi: 10.12259/j.issn.2095-610X.S20230306
[4]	Jiadai TANG, Jing YANG, Hongli SONG, Jiaojiao CHEN, Zhonghui MIAO, Lin XIE. Correlation of Metastatic and Prognostic Factors in 318 Cases of Primary Gastric Cancer. Journal of Kunming Medical University, 2023, 44(2): 75-87. doi: 10.12259/j.issn.2095-610X.S20230218
[5]	Xiaohua LU, Hongxin YUAN. The Analysis of the Correlation between BTLA，CTLA-4 Gene Polymorphisms and the Efficacy and Prognosis of TACE Combined Targeted Therapy for Liver Cancer. Journal of Kunming Medical University, 2023, 44(9): 126-135. doi: 10.12259/j.issn.2095-610X.S20230927
[6]	Yaping JIANG, Hongying YANG, Haohan WANG, Xianling Ning, Xielan YANG. Effect of Different Intestinal Surgical Methods on Prognosis of Patients with Intestinal Invasive Epithelial Ovarian Cancer. Journal of Kunming Medical University, 2023, 44(1): 85-90. doi: 10.12259/j.issn.2095-610X.S20230109
[7]	Zhongshan ZHU, Zhou YANG, Chengchuan JIANG, Xiaobing LI, Dou REN, Cheng HUANG, Weiwei ZHANG, Xiangjun LI, Shunli ZHAO. An Analysis of PLA2G1B Expression and Prognosis in Patients with Lung Adenocarcinoma. Journal of Kunming Medical University, 2022, 43(9): 70-76. doi: 10.12259/j.issn.2095-610X.S20220912
[8]	Yike ZHU, Junsu YANG, Fang QIAN, Haohao WU, Baogang HUANG. Correlation between NLR Value and Prognosis in Patients with Acute Ischemic Stroke before and after Revascularization. Journal of Kunming Medical University, 2022, 43(8): 100-105. doi: 10.12259/j.issn.2095-610X.S20220815
[9]	Changmeng HU, Lin WU. Correlation Between Silva Type and Prognosis of Cervical HPV-associated Adenocarcinoma. Journal of Kunming Medical University, 2022, 43(8): 113-121. doi: 10.12259/j.issn.2095-610X.S20220817
[10]	Gang LI, Jin-song LI, Nan XIE, Chun-mang LI, Lei WEI, Fan CAO, Ying-zhen SU. Expression of B7-H4 in Intrahepatic Cholangiocarcinoma and Its Clinical Significance. Journal of Kunming Medical University, 2021, 42(4): 78-83. doi: 10.12259/j.issn.2095-610X.S20210415
[11]	Jian-pei SU, Wei-meng TIAN, Jun GU, Mi-yu HE. Association between C-reactive Protein/Albumin Ratio and Long-term Prognosis in Elderly Patients with Heart Failure. Journal of Kunming Medical University, 2020, 41(12): 128-132. doi: 10.12259/j.issn.2095-610X.S20201236
[12]	Chang-xian CHEN, Li-ju ZHANG, Xiao-ming JIANG, Zhen-yong ZHANG, Wei-jun LIU. Advances in Treatment of Colorectal Neuroendocrine Tumors. Journal of Kunming Medical University, 2020, 41(12): 155-159. doi: 10.12259/j.issn.2095-610X.S20201242
[13]	Wu Wen Juan . Combination of Heart-type Fatty Acid-binding Protein and Simple Pulmonary Embolism Severity Index for the Assessment of the Short-term Prognosis in Patients with Acute Pulmonary Embolism. Journal of Kunming Medical University,
[14]	Liu Ju Peng . . Journal of Kunming Medical University,
[15]	Ma Lin . . Journal of Kunming Medical University,
[16]	Li Yue Hua . . Journal of Kunming Medical University,
[17]	Xu Jian Xin . . Journal of Kunming Medical University,
[18]	Shi Lei . . Journal of Kunming Medical University,
[19]	Tan Xiang Lai . . Journal of Kunming Medical University,
[20]	Liu Jian Gang . . Journal of Kunming Medical University,